Atria Wealth Solutions’s VanEck Pharmaceutical ETF PPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $241K | Hold |
2,739
| – | – | 0.01% | 1274 |
|
|
2025
Q1 | $250K | Sell |
2,739
-785
| -22% | -$71.5K | ﹤0.01% | 1581 |
|
|
2024
Q4 | $304K | Sell |
3,524
-416
| -11% | -$35.9K | ﹤0.01% | 1518 |
|
|
2024
Q3 | $374K | Sell |
3,940
-7,072
| -64% | -$672K | ﹤0.01% | 1375 |
|
|
2024
Q2 | $1.01M | Sell |
11,012
-6,351
| -37% | -$581K | 0.01% | 892 |
|
|
2024
Q1 | $1.57M | Buy |
17,363
+13,642
| +367% | +$1.24M | 0.02% | 712 |
|
|
2023
Q4 | $303K | Sell |
3,721
-10,667
| -74% | -$868K | ﹤0.01% | 1479 |
|
|
2023
Q3 | $1.15M | Buy |
14,388
+11,088
| +336% | +$885K | 0.02% | 753 |
|
|
2023
Q2 | $260K | Sell |
3,300
-14,625
| -82% | -$1.15M | ﹤0.01% | 1517 |
|
|
2023
Q1 | $1.39M | Buy |
+17,925
| New | +$1.39M | 0.02% | 681 |
|